GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AusCann Group Holdings Ltd (ASX:AC8) » Definitions » Capex-to-Operating-Income

AusCann Group Holdings (ASX:AC8) Capex-to-Operating-Income : 0.00 (As of Dec. 2023)


View and export this data going back to 1986. Start your Free Trial

What is AusCann Group Holdings Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

AusCann Group Holdings's Capital Expenditure for the six months ended in Dec. 2023 was A$0.00 Mil. Its Operating Income for the six months ended in Dec. 2023 was A$-0.26 Mil.

GuruFocus do not calculate Capex-to-Operating-Income if the Operating Income is negative.


AusCann Group Holdings Capex-to-Operating-Income Historical Data

The historical data trend for AusCann Group Holdings's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AusCann Group Holdings Capex-to-Operating-Income Chart

AusCann Group Holdings Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Capex-to-Operating-Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

AusCann Group Holdings Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Capex-to-Operating-Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of AusCann Group Holdings's Capex-to-Operating-Income

For the Drug Manufacturers - Specialty & Generic subindustry, AusCann Group Holdings's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AusCann Group Holdings's Capex-to-Operating-Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, AusCann Group Holdings's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where AusCann Group Holdings's Capex-to-Operating-Income falls into.



AusCann Group Holdings Capex-to-Operating-Income Calculation

AusCann Group Holdings's Capex-to-Operating-Income for the fiscal year that ended in Jun. 2023 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (0) / -2.827
=N/A

AusCann Group Holdings's Capex-to-Operating-Income for the quarter that ended in Dec. 2023 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (0) / -0.258
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AusCann Group Holdings  (ASX:AC8) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.


AusCann Group Holdings Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of AusCann Group Holdings's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.


AusCann Group Holdings (ASX:AC8) Business Description

Traded in Other Exchanges
Address
35 Havelock Street, Level 5, West Perth, Perth, WA, AUS, 6005
AusCann Group Holdings Ltd produces medicinal cannabis. It delivers high-quality, economical, and clinically validated cannabinoid medicinal products.

AusCann Group Holdings (ASX:AC8) Headlines

No Headlines